MedPath

iCanCope With Pain: A Smartphone and Web Self-management Program for Adolescents and Young Adults With Chronic Pain

Not Applicable
Completed
Conditions
Chronic Pain
Interventions
Behavioral: iCanCope app and website
Behavioral: Attention control group
Registration Number
NCT02601755
Lead Sponsor
The Hospital for Sick Children
Brief Summary

Chronic pain in adolescents and young adults (AYA, aged 15-25) is a common problem. Pain that is not treated properly can reduce quality of life. Programs to help AYA learn to live with and manage pain are very important. Our team is developing a smartphone application (app) and website for AYA with chronic pain. The app will help AYA to track pain, sleep, mood, activities, and exercise and help AYA set and achieve goals. The website will give information about pain and how to manage it independently. We will build the program and make sure it is easy to use and understand. We will also test if the program can be put into practice as planned and if AYA using the program feel less pain, have less limitations, and a better quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
302
Inclusion Criteria
  • Diagnosed with chronic pain of at least 3 months duration according to medical chart
  • Able to speak and read English
  • Willing and able to complete online measures
  • Participants are active patients at pain clinic at one of the respective participating study sites
  • Have access to an Internet-connected computer according to self-report.
Exclusion Criteria
  • Moderate to severe cognitive impairments, as assessed by reviewing medical chart and consultation with the patient's healthcare provider
  • Major co-morbid psychiatric (e.g. conversion disorder, depression, anxiety disorder) illness that may impact patient's ability to understand and use the iCanCope with Pain intervention via self-report, as determined by their health care provider
  • Patient from the department of haemology/oncology
  • Participated in the Phase 2B iCanCope usability study
  • Requires urgent CBT treatment as per their health care provider
  • Individuals who have received more than 4 CBT sessions for pain management in the past 6 months, as per their health-care provider and self-report

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
iCanCope app and websiteiCanCope app and websiteIntervention: Behavioral: iCanCope app and website
Attention control groupAttention control groupIntervention: Behavioral: Attention control group
Primary Outcome Measures
NameTimeMethod
Intervention fidelity8 weeks

Any issues or difficulties encountered during implementation of the intervention, control strategy, or outcome measures will be tracked throughout the study by the CRPC.

Acceptability and Satisfaction8 weeks

Participants in the intervention arm will complete the Acceptability e-scale (AES) post-intervention. In addition, a subset of participants from the intervention group will be offered to participate in a qualitative feedback interview to further explore acceptability and satisfaction of the intervention.

Engagement with Intervention8 weeks

Google Analytics will track patterns of app and website usage.

Adherence8 weeks

Adherence will be determined using Google Analytics.

Participant Accrual and Dropout Rates8 weeks

This will be centrally tracked by the clinical research project coordinator (CRPC).

Secondary Outcome Measures
NameTimeMethod
Pain intensity and interference8 weeks

Measured using the short form Brief Pain Inventory (BPI), a 15-item tool that measures pain intensity and impact on functioning.

Self-efficacy8 weeks

Measured with the Pain Self-Efficacy Questionnaire (PSEQ), a 10-item scale that requires patients to take their pain into account when rating their self-efficacy beliefs.

Emotional Functioning8 weeks

Measured using the Hospital Anxiety and Depression Scale (HADS), a 14-item measure for the assessment of anxiety and depressive symptoms.

Sleep Functioning8 weeks

Measured with the Insomnia Severity Index (ISI), a 7-item self-report questionnaire for assessing the nature, severity, and impact of insomnia.

Social Functioning8 weeks

Measured with the Perceived Social Support from Friends (PSS-Fr) Scale, a 20-item scale that assesses the extent to which an individual perceives that their friends fulfill their needs for support.

Pain-Related Knowledge8 weeks

Measured using a modified version of the Medical Issues, Exercise, Pain and Social Support (MEPS) questionnaire, a 27-item measure.

Patients' Global Impression of Change8 weeks

Measured using the PGIC scale, a single item rating by participants of their perceived change during the trial.

Health-Related Quality of Life8 weeks

Measured using the SF-36 Health Survey, a 36-item self-report scale with 8 subscales (Physical Functioning, Role-Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role-Emotional, and Mental Health).

Health Care Utilization8 weeks

Measured using the Chronic Pain Healthcare Utilization Form. (modified from the Ambulatory and Home Care Record)

Adverse effects8 weeks

Will be tracked using the adverse event form.

Trial Locations

Locations (10)

Alberta Children's Hospital

🇨🇦

Calgary, Alberta, Canada

Hamilton Health Sciences

🇨🇦

Hamilton, Ontario, Canada

Mount Sinai Hospital

🇨🇦

Toronto, Ontario, Canada

Stollery Children's Hospital

🇨🇦

Edmonton, Alberta, Canada

The Ottawa Hospital

🇨🇦

Ottawa, Ontario, Canada

University of Saskatchewan

🇨🇦

Saskatoon, Saskatchewan, Canada

IWK Health Centre

🇨🇦

Halifax, Nova Scotia, Canada

Hospital for Sick Children

🇨🇦

Toronto, Ontario, Canada

Nova Scotia Health Authority/Dalhousie University

🇨🇦

Halifax, Nova Scotia, Canada

University of Alberta

🇨🇦

Edmonton, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath